AstraZeneca sees COVID-19 vaccine suffer a setback in nasal spray trialProactive Investors • 10/11/22
INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of LogicBio Therapeutics, Inc. - LOGCPRNewsWire • 10/04/22
Shareholder Alert: Ademi LLP investigates whether LogicBio® Therapeutics, Inc. has obtained a Fair Price in its transaction with AstraZenecaPRNewsWire • 10/03/22
Why AstraZeneca (AZN) Is Buying LogicBio Therapeutics (LOGC) In About A $68 Million DealPulse2 • 10/03/22
LOGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LogicBio Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 10/03/22
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineBusiness Wire • 10/03/22
AstraZeneca, BAT, Ferguson, 4imprint and other exporters get double-benefit from sterling crashProactive Investors • 09/27/22
AstraZeneca gets its third regulatory green light in a matter of weeks for asthma drugProactive Investors • 09/27/22
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug TestInvestors Business Daily • 09/23/22